Warning labels on Mounjaro, Ozempic, and a whole host of other similar type 2 diabetes drugs list gastrointestinal problems, such as the following, as potential side effects associated with them: Abdominal discomfort or pain Nausea Bloating Vomiting Constipation Discolored stools Indigestion Diarrhea However, in entering Ozempic, Mounjaro, and other similar medications into the FDA Adverse Events Reporting System (FAERS) Public Dashboard, thousands of reports of much more serious adverse side effects, including the following, come up: Pancreatitis Gallbladder issues Kidney failure Thyroid tumors Cancer Gastroparesis Gastroparesis, also known as stomach paralysis, is what has led to many patients filing lawsuits against the drugs manufacturers most recently
"GLP-1s already affect appetite, digestion and how quickly food moves through the stomach
In an early-phase clinical trial that tested whether the drug could reduce calorie intake, people who took 50 mg of oral semaglutide ate about 40% fewer calories on average than those taking a placebo
Community Med
Weekly tracking of your weight and blood sugar (if applicable) allows you to catch changes early and address them proactively